PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BIB vs. BBH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between BIB and BBH is 0.92, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.


-0.50.00.51.00.9

Performance

BIB vs. BBH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ProShares Ultra Nasdaq Biotechnology (BIB) and VanEck Vectors Biotech ETF (BBH). The values are adjusted to include any dividend payments, if applicable.

400.00%500.00%600.00%700.00%800.00%JulyAugustSeptemberOctoberNovemberDecember
591.43%
449.66%
BIB
BBH

Key characteristics

Sharpe Ratio

BIB:

0.04

BBH:

0.00

Sortino Ratio

BIB:

0.30

BBH:

0.12

Omega Ratio

BIB:

1.04

BBH:

1.01

Calmar Ratio

BIB:

0.03

BBH:

0.00

Martin Ratio

BIB:

0.15

BBH:

0.01

Ulcer Index

BIB:

9.93%

BBH:

5.03%

Daily Std Dev

BIB:

35.51%

BBH:

16.56%

Max Drawdown

BIB:

-67.24%

BBH:

-72.69%

Current Drawdown

BIB:

-53.50%

BBH:

-27.38%

Returns By Period

In the year-to-date period, BIB achieves a -9.22% return, which is significantly lower than BBH's -4.08% return. Over the past 10 years, BIB has underperformed BBH with an annualized return of -1.34%, while BBH has yielded a comparatively higher 3.89% annualized return.


BIB

YTD

-9.22%

1M

-5.34%

6M

-12.71%

1Y

-1.44%

5Y*

-3.87%

10Y*

-1.34%

BBH

YTD

-4.08%

1M

-1.13%

6M

-5.76%

1Y

-1.55%

5Y*

2.50%

10Y*

3.89%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


BIB vs. BBH - Expense Ratio Comparison

BIB has a 0.95% expense ratio, which is higher than BBH's 0.35% expense ratio.


BIB
ProShares Ultra Nasdaq Biotechnology
Expense ratio chart for BIB: current value at 0.95% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.95%
Expense ratio chart for BBH: current value at 0.35% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.35%

Risk-Adjusted Performance

BIB vs. BBH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra Nasdaq Biotechnology (BIB) and VanEck Vectors Biotech ETF (BBH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for BIB, currently valued at 0.04, compared to the broader market0.002.004.000.040.00
The chart of Sortino ratio for BIB, currently valued at 0.30, compared to the broader market-2.000.002.004.006.008.0010.000.300.12
The chart of Omega ratio for BIB, currently valued at 1.04, compared to the broader market0.501.001.502.002.503.001.041.01
The chart of Calmar ratio for BIB, currently valued at 0.03, compared to the broader market0.005.0010.0015.000.030.00
The chart of Martin ratio for BIB, currently valued at 0.15, compared to the broader market0.0020.0040.0060.0080.00100.000.150.01
BIB
BBH

The current BIB Sharpe Ratio is 0.04, which is higher than the BBH Sharpe Ratio of 0.00. The chart below compares the historical Sharpe Ratios of BIB and BBH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.50JulyAugustSeptemberOctoberNovemberDecember
0.04
0.00
BIB
BBH

Dividends

BIB vs. BBH - Dividend Comparison

BIB's dividend yield for the trailing twelve months is around 0.89%, while BBH has not paid dividends to shareholders.


TTM20232022202120202019201820172016201520142013
BIB
ProShares Ultra Nasdaq Biotechnology
0.89%0.07%0.03%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
BBH
VanEck Vectors Biotech ETF
0.00%0.43%0.47%0.21%0.36%0.34%0.50%0.55%0.30%0.27%0.00%0.00%

Drawdowns

BIB vs. BBH - Drawdown Comparison

The maximum BIB drawdown since its inception was -67.24%, smaller than the maximum BBH drawdown of -72.69%. Use the drawdown chart below to compare losses from any high point for BIB and BBH. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%JulyAugustSeptemberOctoberNovemberDecember
-53.50%
-27.38%
BIB
BBH

Volatility

BIB vs. BBH - Volatility Comparison

ProShares Ultra Nasdaq Biotechnology (BIB) has a higher volatility of 11.90% compared to VanEck Vectors Biotech ETF (BBH) at 5.16%. This indicates that BIB's price experiences larger fluctuations and is considered to be riskier than BBH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%14.00%JulyAugustSeptemberOctoberNovemberDecember
11.90%
5.16%
BIB
BBH
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab